These innovative medications , Retatrutide, represent a remarkable advancement in managing obesity and conceivably related ailments . They are classified as GLP-1 receptor stimulators, signifying they function to emulate the body's GLP-1 peptide, enhancing insulin production and lowering hunger . Although Tirzepatide each functions relatively simil